Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?
Journal Title: Journal of Urological Surgery - Year 2019, Vol 6, Issue 2
Abstract
Oral pharmacotherapy constitutes second-line treatment for overactive bladder (OAB) after lifestyle modifications, bladder retraining, and pelvic floor muscle exercises. Antimuscarinics have an established role in the treatment of OAB. However, antimuscarinics are known to have low persistence rates in clinical practice. Mirabegron is an oral β3-adrenoreceptor agonist which has emerged as an alternative to antimuscarinics for managing OAB. Overall, mirabegron has similar clinical efficacy to antimuscarinics and is superior to placebo. Mirabegron has been generally well tolerated in both interventional and non-interventional studies. Persistence has been shown to be higher with mirabegron than with antimuscarinics in realworld studies. Increased blood pressure is associated with mirabegron and therefore its use is contraindicated in patients with severe uncontrolled hypertension. However, a low rate of treatment cessation due to cardiovascular issues has been noted in clinical trials. Mirabegron’s utility in the elderly patient population has been well supported with promising efficacy and safety outcomes. New data from a prospective placebo-controlled randomized trial in older OAB patients is expected to be published soon. Mirabegron does not interfere with detrusor contractions during the emptying phase of the micturition cycle and hence lacks any significant effect on post-void residual volume. Mirabegron can be combined with antimuscarinics to synergize clinical effectiveness. Overall, mirabegron represents a well-tolerated and effective medical treatment option for OAB. Mirabegron could be used as an alternative to antimuscarinics, especially in patients who do not improve with antimuscarinics and/or experience bothersome side effects for whom anticholinergic load may be a relevant consideration.
Authors and Affiliations
Ömer Acar, Mustafa Levent Erton, Tufan Tarcan
Keywords
Related Articles
- EP ID EP48971
- DOI 10.4274/jus.galenos.2019.2533
- Views 368
- Downloads 0
Incidental Prostate Adenocarcinoma in Prostate Transurethral Resections: Our Eight Year Experience
Objective: Incidental early-stage prostate cancer (PC) can be detected in patients undergoing transurethral resection of the prostate (TURP) due to benign prostatic hyperplasia (BPH). In our study, we investigated the in...
Inflammatory Myofibroblastic Pseudotumour of the Urinary Bladder in a Young Male: A Case Report
Inflammatory myofibroblastic tumours (IMTs) are relatively rare entities with an uncertain pathogenesis and are classified as tumours of intermediate biological potential. IMTs of the urinary bladder are generally benign...
Testicular Torsion: Experience in a Tertiary Urology Referral Centre
Objective: To evaluate the patients who presented to our department due to testicular torsion (TT) and investigate the risk factors affecting orchiectomy in patients with TT. Materials and Methods: Between November 2005...
Effect of Mirabegron on Intraocular Pressure in Patients with Glaucoma
Objective: Assessment of the effects of mirabegron treatment used for overactive bladder (OAB) symptoms in glaucoma patients on intraocular structures. Materials and Methods: One hundred-twenty six female glaucoma patie...
Are Haematological Parameters Reliable for Differential Diagnosis of Testicular Torsion and Epididymitis?
Objective: Acute scrotum is a urological emergency that can result in loss of the testis if the differential diagnosis is not made immediately. Testicular torsion (TT) and epididymo-orchitis (EO) are the two most common...